ChargePoint Technology expands smart monitoring technology into North America
Company's VERIFI smart monitoring hub allows production teams to manage and maintain their containment solution which, in turn, helps assure operator safety and sterility assurance related performance during pharmaceutical manufacturing processes.
Powder containment and sterile transfer solutions provider, ChargePoint Technology has achieved HazLoc (Hazardous Area) certification for VERIFI to further support customers in North America.
The HazLoc certification has been granted by the Canadian Standards Association (CSA) and will enable ChargePoint to expand its VERIFI smart monitoring hub into the North American market.
The VERIFI smart monitoring hub is a first-of-its-kind technology which monitors usage of ChargePoint’s split butterfly valve (SBV), used to provide containment during pharmaceutical manufacturing.
VERIFI continuously records valve-use providing data that allows production teams to manage and maintain their containment solution in a proactive and efficient manner. In turn, this helps assure operator safety and sterility assurance related performance during pharmaceutical manufacturing processes.
Chris Rombach, president at ChargePoint Technology commented: “Having seen the positive impact and excellent response to VERIFI in European markets, we are proud to bring VERIFI to North America. We can now give our customers more autonomy to improve operational performance and productivity, as well as helping them manage risk in their manufacturing processes.”
ChargePoint Technology has worked closely with CSA over the last two years to achieve the certification for Class 1 Zone 0 and Class II/III Zone 21, which was granted after an inspection of the company’s Liverpool, UK manufacturing headquarters in late 2018.
The company already holds Atmosphere Explosive (ATEX) and International Electro Commission (IEC) Explosive (Ex) certifications, allowing the use of VERIFI in hazardous environments in Europe.
Adam Bunyard, director of innovation and technology at ChargePoint Technology said: “Our customer base in the North American market is rapidly growing and we are excited to now be able to support existing and future customers with our unique smart monitoring technology.
“As the industry moves towards Industry 4.0, ChargePoint will remain at the forefront of contained transfer innovation, responding to the challenges of today and tomorrow.”
ChargePoint Technology’s solutions also include its AseptiSafe range of SBVs, designed to increase sterility assurance for ingredient and small component transfers in aseptic processing.
All of ChargePoint Technology’s transfer solutions are independently performance tested to the ISPE SMEPAC guidelines. The company works with select material handling solution partners globally to ensure an integrated high containment handling process is successfully achieved.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance